Report no. 37/2012

Pursuant to § 33 of the Regulation of the Council of Ministers of 19 February 2009 on current and periodical information provided by issuers of securities and conditions of deeming information required by the regulations of a non-member country equal, the Management Board of EMC Instytut Medyczny S.A. makes public the information of the completion of closed offering of series G shares under the pre-emptive rights  in connection with these shares being introduced to trading on the official market.

On 30 March 2011, The Ordinary General Meeting of EMC Medical Institute SA resolved to: increase share capital by new issue of series G shares in a public offering with pre-emptive rights for existing shareholders and amending the Articles of Association.
The content of  resolutions adopted by the abovementioned Ordinary General Meeting was made public in the current report No. 55/2011 of 30 March 2011.

1. Opening and closing dates of the public offering:
The date of commencement of acceptance of  initial and additional subscriptions under the exercise of pre-emptive rights : December 7,2011. The final date of accepting initial and additional subscriptions under the exercise of pre-emptive rights: December 21,2011. Accepting subscriptions for shares that have not been taken up under the exercise of pre-emptive rights started on  5 January 2012 and ended on 27 February 2012.
2. Date of the allocation of the shares:
The Series G shares, which  were subscribed for in the primary and additional offerings and the shares not taken up under the preemptive right was allocated on  28 February 2012.
3. Number of shares subject to the subscription: 1.189.602 Series G shares
4.The reduction rate in individual tranches:
The subscription has not been split into tranches.
The number of allocated Series G Shares  is not less than the number of securities which have been subscribed for. The allocation rate for additional subscription was 1.
5. Number of shares covered by subscription orders within the scope of:
 primary subscription: 152.363 Series G Shares,
 additional subscription: 1.037.239 Series G Shares,
subscriptions  for the shares not taken up under the primary and additional subscriptions: 0 Series G Shares.
6. The number of shares allocated within the scope of the completed subscription: 1.189.602 Series G Shares.  152.363 Series G Shares have been allocated within the scope of primary subscription in accordance with subscription orders placed..
1.037.239 Series G Shares have been allocated within the scope of additional subscription.
0 Series G Shares have been allocated within the scope of subscription for the shares not taken up under the primary and additional subscriptions.
7. The price at which the shares were acquired (taken up): PLN 7,86
8. Number of persons who subscribed for the shares within the scope of:
 primary subscription-86,
additional subscription-11,
subscriptions  for the shares not taken up under the primary and additional subscriptions-0.
9. The number of persons who were allocated shares within the scope of:
 primary subscription-86,
additional subscription-11,
subscriptions  for the shares not taken up under the primary and additional subscriptions-0.
10. The names (business names) of the underwriters who were allocated the shares in performance of the underwriting agreements: underwriting agreements were not concluded by the Company.
11. The value of the subscription: PLN 9,350,271.72
12. The total costs that were included in the issue costs:
So far, both estimated and posted costs of the issue of Series G Shares, have amounted to: PLN 791.648, including:
a)    preparation and completion of the offering: PLN 476.898
b)    underwriters’ fees: PLN 0,
c)    drafting the prospectus along with the costs of counselling : PLN 274.950;
d)    promotion of the offering: PLN 0.
On the day of this report, due to the lack of  final settlement of issue costs,  expenditures have been estimated and included in the  issue cost to the best knowledge of the Issuer.
Pursuant to Article 36 (2 b) of the Act on Accounting the cost of issue of  Series G Shares will decrease the reserve capital of the Company received from the issue of the shares up to the value of the surplus of the issue price over the nominal value thereof.
13. The average cost of the issuance of the Series G Shares per one subscribed share amounted to: PLN 0.63.
 

The Management Board of EMC Instytut Medyczny S.A. hands over the correction to the current report No. 37/2012 of 03/14/2012 on the completion of the subscription of Series G Shares.

was

...
5. Number of shares covered by subscription orders within the scope of:
 primary subscription: 152.363 Series G Shares,
 additional subscription: 1.037.239 Series G Shares,
subscriptions  for the shares not taken up under the primary and additional subscriptions: 0 Series G Shares.
6. The number of shares allocated within the scope of the completed subscription: 1.189.602 Series G Shares. 152.363 Series G Shares have been allocated within the scope of primary subscription.
1.037.239 Series G Shares have been allocated within the scope of additional subscription.
0 Series G Shares have been allocated within the scope of subscription for the shares not taken up under the primary and additional subscriptions.
...
8. Number of persons who subscribed for the shares within the scope of:
 primary subscription-86,
additional subscription-11,
subscriptions  for the shares not taken up under the primary and additional subscriptions-0.
9. The number of persons who were allocated shares within the scope of:
 primary subscription-86,
additional subscription-11,
subscriptions  for the shares not taken up under the primary and additional subscriptions-0.

is
...
5. Number of shares covered by subscription orders within the scope of:
 primary and additional subscriptions: 152.363 Series G Shares,
subscriptions  for the shares not taken up under the primary and additional subscriptions: 1.037.239 Series G Shares.
6. The number of shares allocated within the scope of the completed subscription: 1.189.602 Series G Shares. 152.363 Series G Shares have been allocated within the scope of primary and additional subscriptions in accordance with subscription orders placed.
1.037.239 Series G Shares have been allocated within the scope of subscription for the shares not taken up under the primary and additional subscriptions.
8. Number of persons who subscribed for the shares within the scope of:
 primary and additional subscriptions -86,
subscriptions  for the shares not taken up under the primary and additional subscriptions-11.
9. The number of persons who were allocated shares within the scope of:
 primary and additional subscriptions-86,
subscriptions  for the shares not taken up under the primary and additional subscriptions-11.
All other elements of the current report remain unchanged.

Below is the correct content of the revised current report No. 37/2012:

Pursuant to § 33 of the Regulation of the Council of Ministers of 19 February 2009 on current and periodical information provided by issuers of securities and conditions of deeming information required by the regulations of a non-member country equal, the Management Board of EMC Instytut Medyczny S.A. makes public the information of the completion of closed offering of series G shares under the pre-emptive rights  in connection with these shares being introduced to trading on the official market.

On 30 March 2011 The Ordinary General Meeting of EMC Medical Institute SA resolved to: increase share capital by new issue of series G shares in a public offering with pre-emptive rights for existing shareholders and amending the Articles of Association.
The content of  resolutions adopted by the abovementioned Ordinary General Meeting was made public in the current report No. 55/2011 of 30 March 2011.

1. Opening and closing dates of the public offering:
The date of commencement of acceptance of  initial and additional subscriptions under the exercise of pre-emptive rights : December 7,2011. The final date of accepting initial and additional subscriptions under the exercise of pre-emptive rights: December 21,2011. Accepting subscriptions for shares that have not been taken up under the exercise of pre-emptive rights started on  5 January 2012 and ended on 27 February 2012.
2. Date of the allocation of the shares:
The Series G shares, which  were subscribed for in the primary and additional offerings and the shares not taken up under the pre-emptive right was allocated on  28 February 2012.
3. Number of shares subject to the subscription: 1.189.602 Series G shares
4. The reduction rate in individual tranches:
The subscription has not been split into tranches.
The number of allocated Series G Shares  is not less than the number of securities which have been subscribed for. The allocation rate for additional subscription was 1.
5. Number of shares covered by subscription orders within the scope of:
 primary and additional subscriptions: 152.363 Series G Shares,
subscriptions  for the shares not taken up under the primary and additional subscriptions: 1.037.239 Series G Shares.
6. The number of shares allocated within the scope of the completed subscription: 1.189.602 Series G Shares. 152.363 Series G Shares have been allocated within the scope of primary and additional subscriptions in accordance with subscription orders placed.
1.037.239 Series G Shares have been allocated within the scope of subscription for the shares not taken up under the primary and additional subscriptions.
8. Number of persons who subscribed for the shares within the scope of:
 primary and additional subscriptions-86,
subscriptions  for the shares not taken up under the primary and additional subscriptions-11.
9. The number of persons who were allocated shares within the scope of:
 primary and additional subscriptions-86,
subscriptions  for the shares not taken up under the primary and additional subscriptions-11.
10. The names (business names) of the underwriters who were allocated the shares in performance of the underwriting agreements: underwriting agreements were not concluded by the Company.
11. The value of the subscription: PLN 9,350,271.72
12. The total costs that were included in the issue costs:
So far, both estimated and posted costs of the issue of Series G Shares, have amounted to: PLN 791.648, including:
a)    preparation and completion of the offering: PLN 476.898
b)    underwriters’ fees: PLN 0,
c)    drafting the prospectus along with the costs of counselling : PLN 274.950;
d)    promotion of the offering: PLN 0.
On the day of this report, due to the lack of  final settlement of issue costs,  expenditures have been estimated and included in the  issue cost to the best knowledge of the Issuer.
Pursuant to Article 36 (2 b) of the Act on Accounting the cost of issue of  Series G Shares will decrease the reserve capital of the Company received from the issue of the shares up to the value of the surplus of the issue price over the nominal value thereof.
13. The average cost of the issuance of the Series G Shares per one subscribed share amounted to: PLN 0.63.

Legal basis: § 6 (2) of the Regulation of the Minister of Finance of 19 February 2009 on current and periodic information published by issuers of securities and conditions for deeming information required by the regulations of a non-member state equal  (Official Journal of 28 February 2009, No. 33, item. 259, as amended).